The Mexican Association of Pharmaceutical Research Industries (AMIIF) represents the innovative pharmaceutical industry in Mexico, advocating for innovation and promoting dialogue with local authorities. AMIIF’s Executive Director, Cristobal Thompson, discusses the country and the organization’s response to the COVID-19 pandemic and outlines Mexico’s healthcare challenges and how they have evolved since 2020.
We are on a permanent learning curve with the government and pushing forward as much as we can for new molecule approvals, so patients have access to medicines
